Literature DB >> 22753764

New anticancer agents: recent developments in tumor therapy.

Riyasat Ali1, Zeenat Mirza, Ghulam M D Ashraf, Mohammad Amjad Kamal, Shakeel Ahmed Ansari, Ghazi Abdullah Damanhouri, Adel Mohammad Abuzenadah, Adeel Ga Chaudhary, Ishfaq Ahmed Sheikh.   

Abstract

Increasing recurrence of mammalian tumors and severe side-effects of chemotherapeutic agents reduce the clinical efficacy of a large variety of anticancer agents that are currently being used. Thus, there is always a constant need to develop alternative or synergistic anticancer drugs with minimal side-effects. One important strategy to develop effective anticancer agents is to study into anticancer agents derived from natural sources. Anticancer agents derived from plants and their derivatives have been proven to be effective for cancer prevention and therapeutics. Vinca alkaloid and their derivatives, alone and in combination with therapeutic agents, have been used for a long time for the treatment of various types of cancers. Polyphenols form one of the most important and extensively used classes of plant-derived therapeutics for cancer prevention or chemotherapy. The present review highlights a plethora of studies focused on the antineoplastic properties of plant-derived chemicals, such as Vinca alkaloid, saponins, and flavonoids.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753764

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  35 in total

Review 1.  Role of phytochemicals in colorectal cancer prevention.

Authors:  Yu-Hua Li; Yin-Bo Niu; Yang Sun; Feng Zhang; Chang-Xu Liu; Lei Fan; Qi-Bing Mei
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

2.  Sensitive liquid chromatography/tandem mass spectrometry method for the determination of two novel highly lipophilic anticancer drug candidates in rat plasma and tissues.

Authors:  Shirin Hooshfar; Michael R Linzey; Daqing Wu; Lajos Gera; Kenza Mamouni; Xin Li; Yanhua Chen; Yang Yang; Oluwasegun Olorunyolemi; Michael G Bartlett
Journal:  Biomed Chromatogr       Date:  2017-09-12       Impact factor: 1.902

Review 3.  Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer.

Authors:  Michelle G Zhang; John Y Lee; Ryan A Gallo; Wensi Tao; David Tse; Ravi Doddapaneni; Daniel Pelaez
Journal:  Pharmacol Res       Date:  2017-12-02       Impact factor: 7.658

Review 4.  Pharmacological management of ionizing radiation injuries: current and prospective agents and targeted organ systems.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Expert Opin Pharmacother       Date:  2020-01-11       Impact factor: 3.889

5.  Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53.

Authors:  Hong-Tao Zhang; Yun-Long Wang; Jie Zhang; Qin-Xian Zhang
Journal:  Tumour Biol       Date:  2014-02

6.  Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.

Authors:  Antonino Maria Spartà; Daniela Bressanin; Francesca Chiarini; Annalisa Lonetti; Alessandra Cappellini; Cecilia Evangelisti; Camilla Evangelisti; Fraia Melchionda; Andrea Pession; Alice Bertaina; Franco Locatelli; James A McCubrey; Alberto M Martelli
Journal:  Cell Cycle       Date:  2014-05-29       Impact factor: 4.534

7.  Betulin inhibits lung carcinoma proliferation through activation of AMPK signaling.

Authors:  Xian-Dong Li; Yi-Jie Zhang; Ji-Chang Han
Journal:  Tumour Biol       Date:  2014-08-08

Review 8.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

9.  Mechanistic elucidation of the antitumor properties of withaferin a in breast cancer.

Authors:  Arumugam Nagalingam; Panjamurthy Kuppusamy; Shivendra V Singh; Dipali Sharma; Neeraj K Saxena
Journal:  Cancer Res       Date:  2014-04-14       Impact factor: 12.701

10.  Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment.

Authors:  Yiming Niu; Jing Bai; Roger D Kamm; Yitao Wang; Chunming Wang
Journal:  Mol Pharm       Date:  2014-02-24       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.